Response Genetics' Q4, FY 2010 Revenues Rise | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Response Genetics today reported that its fourth-quarter revenues jumped 88 percent as sales for its ResponseDX genetic tests rose sharply year over year.

The Los Angeles-based genetic test maker reported total revenues of $6.4 million for the three-month period ended Dec. 31, compared to $3.4 million for the fourth quarter of 2009. Sales for its ResponseDX genetic tests jumped 82 percent to $3.1 million from $1.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.